Catalog No.
YVV36101
Expression system
E. coli
Species
Newcastle disease virus strain GPMV/QY97-1
Protein length
Pro126-Ile571
Predicted molecular weight
51.48 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
AAF06665.1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
HN, Hemagglutinin-neuraminidase
A novel chimpanzee adenovirus vector vaccine for protection against infectious bronchitis and Newcastle disease in chickens., PMID:40375108
Development and evaluation of immunogenicity and protective efficacy of two recombinant attenuated newcastle disease viruses expressing the VP2 protein of infectious bursal disease virus., PMID:40339237
Serum reactivity analysis with inactivated GVII-matched vaccine-Payavax G79®: Comparison of B-cell epitopes in NDV-vaccine strains., PMID:40335223
Genotype I Newcastle Disease Virus, Isolated from Wild Duck, Can Protect Chickens Against Newcastle Disease Caused by Genotype VII., PMID:40333124
Evaluation of Different Machine Learning Approaches to Predict Antigenic Distance Among Newcastle Disease Virus (NDV) Strains., PMID:40285009
Comparative pathology of ducks experimentally inoculated with three different recombinant Newcastle disease viruses., PMID:40101975
La Sota-vectored recombinant vaccine with chimeric hemagglutinin-neuraminidase for enhanced protection against highly pathogenic pigeon paramyxovirus type 1., PMID:39993343
Recent advancements in the diverse roles of polymerase-associated proteins in the replication and pathogenesis of Newcastle disease virus., PMID:39800751
Clinical and molecular identification of Newcastle disease virus in naturally infected chicks in Thi-Qar province of Iraq., PMID:39737025
The Role of Dual Mutations G347E and E349D of the Pigeon Paramyxovirus Type 1 Hemagglutinin-Neuraminidase Protein In Vitro and In Vivo., PMID:39728932
Development of a Novel Chimeric ND-GP cVLPs Vaccine for the Prevention of Goose-Derived Newcastle Disease and Gosling Plague., PMID:39597655
Multi-Epitopic Peptide Vaccine Against Newcastle Disease Virus: Molecular Dynamics Simulation and Experimental Validation., PMID:39591153
The heterologous expression of novel recombinant protein composed of HN and F moieties of Newcastle disease virus and immunogenicity evaluation in mouse model., PMID:39534294
Pongamia pinnata L. seed-derived karanjin as prominent antiviral agent against Newcastle disease virus., PMID:39454229
Investigation of the toxicity and safety concerns of transgenic maize seeds expressing immunogenic F and HN protein genes against Newcastle disease virus., PMID:39296948
Arginyltransferase 1 (ATE1)-mediated proteasomal degradation of viral haemagglutinin protein: a unique host defence mechanism., PMID:39207120
Computational exploration and molecular dynamic simulation for the discovery of antiviral agents targeting Newcastle disease virus., PMID:39197691
NDV targets the invasion pathway in malaria parasite through cell surface sialic acid interaction., PMID:39092913
Unraveling dynamics of paramyxovirus-receptor interactions using nanoparticles displaying hemagglutinin-neuraminidase., PMID:39052678
Genetic characterization of pigeon- origin avian avulavirus-1 reveals unique substitutions in F and HN proteins., PMID:39035477
Nucleotide sequence characterization, amino acid variations and 3D structural analysis of HN protein of the NDV VIId genotype., PMID:39031626
The haemagglutinin-neuraminidase protein of velogenic Newcastle disease virus enhances viral infection through NF-κB-mediated programmed cell death., PMID:38715081
The W195 Residue of the Newcastle Disease Virus V Protein Is Critical for Multiple Aspects of Viral Self-Regulation through Interactions between V and Nucleoproteins., PMID:38675926
Evaluation of the Immunity Responses in Mice to Recombinant Bacillus subtilis Displaying Newcastle Disease Virus HN Protein Truncations., PMID:38543490
The HN protein of Newcastle disease virus induces cell apoptosis through the induction of lysosomal membrane permeabilization., PMID:38354122
Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein., PMID:38317245
The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect., PMID:38178138
Protective effects of a novel chimeric virus-like particle vaccine against virulent NDV and IBDV challenge., PMID:38065771
Detection and molecular characterization of virulent Newcastle disease virus (subgenotype VII.2) in broiler chickens in Northern Vietnam., PMID:38023274
The heat-labile enterotoxin B subunit bio-adjuvant linked to Newcastle disease virus recombinant hemagglutinin neuraminidase elicited a humoral immune response in animal model., PMID:37953579
Direct interaction of the molecular chaperone GRP78/BiP with the Newcastle disease virus hemagglutinin-neuraminidase protein plays a vital role in viral attachment to and infection of culture cells., PMID:37920471
Cellular vimentin regulates the infectivity of Newcastle disease virus through targeting of the HN protein., PMID:37848995
Antigenic variation in hemagglutinin-neuraminidase of Newcastle disease virus isolated from Tibet, China., PMID:37690146
C-terminal truncation of the hemagglutinin-neuraminidase (HN) protein enhances the virulence and immunogenicity of Newcastle disease virus (NDV) vaccine strain V4., PMID:37418014
Protection against genotype VII Newcastle disease virus by a mucosal subunit vaccination based on bacterium-like particles bearing the F or HN antigen., PMID:37315677
Molecular characterization and phylogenetic study of the hemagglutinin-neuraminidase gene of newcastle disease virus isolated from peacock (Pavo cristatus) and Turkey (Meleagris) and its comparison with broiler isolates., PMID:37254016
Multiple potential recombination events among Newcastle disease virus genomes in China between 1946 and 2020., PMID:37206434
Simultaneous Expression of Chicken Granulocyte Monocyte Colony-Stimulating Factor and the Hemagglutinin-Neuraminidase Epitope of the Virulent Newcastle Disease Virus Genotype VII C22 Strain in a Functional Synthetic Recombinant Adenovirus as a Genotype-Matched Vaccine with Potential Antiviral Activity., PMID:37036344
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses., PMID:36848501
Evaluation of Newcastle disease virus LaSota strain attenuated by codon pair deoptimization of the HN and F genes for in ovo vaccination., PMID:36563582
Biological Significance of Dual Mutations A494D and E495K of the Genotype III Newcastle Disease Virus Hemagglutinin-Neuraminidase In Vitro and In Vivo., PMID:36366435
Simultaneous detection of velogenic Newcastle disease virus of genotype XIII 2.2 from spot-billed pelican and backyard chicken: implications to the viral maintenance and spread., PMID:36029088
Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability., PMID:35758932
Amino Acid Mutations in Hemagglutinin-Neuraminidase Enhance the Virulence and Pathogenicity of the Genotype III Newcastle Disease Vaccine Strain After Intravenous Inoculation., PMID:35711809
Quantitative regulation of the thermal stability of enveloped virus vaccines by surface charge engineering to prevent the self-aggregation of attachment glycoproteins., PMID:35679257
Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken., PMID:35632659
[Expression of NDV HN protein in rice and development of a semi-quantitative rapid method for detection of antibodies]., PMID:35611743
Expression and characterization of hemagglutinin-neuraminidase protein from Newcastle disease virus in Bacillus subtilis WB800., PMID:35608724
Prediction and analysis of multi epitope based vaccine against Newcastle disease virus based on haemagglutinin neuraminidase protein., PMID:35531218
Continuous surveillance revealing a wide distribution of class I Newcastle disease viruses in China from 2011 to 2020., PMID:35349584
For research use only. Not for human or drug use.
